MedTech Week Magazine 2020 At a glance

Highlights from the 6th Edition of the Award-Winning MedTech Week Magazine

social white padded

7 million

social media impressions

Future generations may ask: What did you do when the COVID-19 crisis struck? The pandemic challenged all of us, personally and professionally, and I am proud to be part of a sector that found solutions to our shared problems. In the face of adversity, we jumped into action.

Serge Bernasconi
Chief Executive, MedTech Europe
map box






Active Campaigning


expert & patient




during this week


media impressions


website pageviews


billboard views

Search MedTech Week magazine
Or filter articles & perspectives by tags
  • Patient
  • Expert
  • Value of medtech
  • Digital Health
  • Innovation
  • Career and education
  • Regulations and legal
  • Cardiology
  • Homecare
  • Diagnostics
  • Covid-19
  • Diabetes
  • Ophthalmology
  • Value-based healthcare
  • Chronic conditions


mHealth at a tipping point

mHealth at a tipping point?

COVID-19 showed the value of digital health technologies. Now, financing new care pathways using such technology enables mHealth apps to go mainstream.

Health & research  why regulations matter

Health & research: why regulations matter

Researchers and clinicians must understand the regulatory rules so we can shape and apply them.

Medtech in a time of crisis

Medtech in a time of crisis

How the COVID-19 crisis changed my perception of the medical device regulatory framework

Digital disruption in diabetes care

Digital disruption in diabetes care

What a rollercoaster the last few months have been – a world has been defined through the lens of a global COVID-19 pandemic has embraced digital technology

Tele  medicine in the spotlight

Telemedicine in the spotlight

How the COVID-19 crisis changed my perception of the medical device regulatory framework

Pharmacys digital  future

Pharmacy’s digital future

A pharmacy student’s view on digitalisation and eHealth in community pharmacies across Europe

Regions can drive value

Regions can drive value

Procurement of innovative solutions by regional authorities will help public healthcare systems rise to the challenges we face

The digital  transformation  of cancer  care

The digital transformation of cancer care

New Digital Health Network will focus on embracing new and existing digital tools

Europes post crisis vision

Europe’s post-crisis vision

The COVID-19 pandemic sparked a crisis in our health systems from which we must learn – research and innovation on post-acute and long-term care are essential

Wanted  EU action on health

Wanted: EU action on health

The new second mandate of the European Parliament Interest Group is an opportunity to focus on innovation in health and social care

Medtech in a time of crisis

How the COVID-19 crisis changed my perception of the medical device regulatory framework

Kyun Thibaut

Managing Director, COVARTIM

From February to May 2020, while fighting the coronavirus, Belgium faced a shortage of medical devices. Not only were health professionals running out of masks, but hospitals were also low on closed-loop aspiration systems, swabs, connectors, valves, and so on.

I was a member of multiple task forces, operating at federal and private levels, seeking solutions. We were confronted with a challenge: there was simply not enough time to follow the classic process to launch a new product on the market.

However, no matter how bad the situation is, regulations and rules are to be followed to ensure safety and performance of any new medical device. Up to that point in time I had believed the regulatory framework was inflexible; I was wrong.

On top of EU recommendations to allow the temporary usage of non-CE marked devices, Belgium introduced a special framework to give hospitals access to new solutions that had not followed the traditional regulatory pathway.

This scheme allowed the delivery of products in record time and we believe this was decisive at the peak of the crisis. During the pandemic, CE marked products were of course still circulating, but there were other products circulating alongside them. Products which entered the market via emergency procedures will need to either disappear or undergo CE marking once the crisis passes.

I am sure that with a strong government willingness to develop sustainable local production capabilities of some critical medical devices, new stakeholders will emerge to help our country to prepare in the future.

Medtech Week magazine archive

Click on the covers to view full magazine online